Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1354 (LINC01354)

Target
LINC01354
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1354 (LINC01354) is a cytoplasmic long non-coding RNA of 944 nucleotides located on chromosome 1. It is upregulated in several human cancers, including gastric cancer, colorectal cancer, lung cancer, and osteosarcoma. Functionally, LINC01354 acts as an oncogene, promoting tumor cell proliferation, migration, invasion, and epithelial-mesenchymal transition—largely via two distinct molecular mechanisms: - acting as a competing endogenous RNA (ceRNA) for microRNAs (for example, sponging miR-153-5p to regulate CADM2 in gastric cancer, or miR-340-5p/ATF1 signaling in lung cancer), - stabilizing mRNA transcripts (stabilizing β-catenin mRNA through interaction with hnRNP-D, thereby activating the Wnt/β-catenin signaling pathway in colorectal cancer). Overexpression of LINC01354 correlates with poor prognosis, increased tumor size, metastasis, and advanced clinical stage in several cancer types, making its expression a potential biomarker for diagnosis and prognosis. Current research focuses on its functional role in tumor biology; no marketed therapeutics target LINC01354 directly at this time.

Other names
LINC01354Long intergenic non-protein coding RNA 1354
02

Mechanism of action

Not applicable: No targeted drugs are known.

03

Biological functions

Regulation of gene expression (post-transcriptional and via competing endogenous RNA mechanisms)Stabilization of target mRNA (such as CTNNB1 for β-catenin)Promotion of epithelial-mesenchymal transition (EMT)Promotion of cell proliferation, migration, and invasion in various cancer cells
04

Disease associations

Cancer (specifically reported in gastric cancer, colorectal cancer, lung cancer, osteosarcoma, and endometrial cancer)
05

Biomarkers

Elevated expression of LINC01354 in tumor tissues (suggested as a prognostic and diagnostic biomarker in colorectal cancer and gastric cancer)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1354 (LINC01354).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1354 (LINC01354).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call